StockWatch
·
Medical/Dental Instruments
Quarterly ResultApr 30, 2026, 05:27 PM

IRTC Q1 Revenue +25.7% to $199.4M; Net Loss Narrows to $13.9M

AI Summary

iRhythm Holdings, Inc. reported a strong increase in revenue for the first quarter of 2026, rising 25.7% year-over-year to $199.4 million. The company also significantly narrowed its net loss to $13.9 million, or $0.43 per share, compared to a $30.7 million loss in the prior year period. However, net cash used in operating activities increased substantially, indicating higher operational cash burn despite improved profitability metrics. The company also completed a corporate holding company restructuring in January 2026.

Key Highlights

  • IRTC Q1 2026 revenue increased 25.7% to $199.4 million from $158.7 million in Q1 2025.
  • Net loss narrowed significantly to $13.9 million ($0.43 per share) in Q1 2026 from $30.7 million ($0.97 per share) in Q1 2025.
  • Gross profit rose 29.4% to $141.4 million in Q1 2026 compared to $109.2 million in Q1 2025.
  • Net cash used in operating activities increased to $26.2 million in Q1 2026 from $7.9 million in Q1 2025.
  • Contracted third-party payors contributed $106.8 million (53%) of Q1 2026 revenue.
  • Centers for Medicare & Medicaid Services (CMS) revenue was $51.4 million (26%) in Q1 2026.
  • Total current assets decreased to $680.6 million at March 31, 2026, from $702.8 million at December 31, 2025.
  • Total stockholders' equity increased to $161.2 million at March 31, 2026, from $152.7 million at December 31, 2025.